CA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

CA Cancer J Clin 1975; 25:187-197
doi: 10.3322/canjclin.25.4.187
© 1975 American Cancer Society
This Article
Right arrow Full Text (PDF) Freely available
Right arrow Submit a letter to the editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McKhann, C. F.
Right arrow Articles by Yarlott, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McKhann, C. F.
Right arrow Articles by Yarlott, M. A., Jr.

CA: A Cancer Journal for Clinicians, Vol 25, 187-197, Copyright © 1975 by American Cancer Society

Tumor Immunology

Charles F. McKhann M.D.1 and Melvin A. Yarlott Jr. M.D.2

1 Professor of Surgery and Microbiology, Department of Surgery, University of Minnesota, Minneapolis, Minnesota.
2 Clinical Fellow, Department of Surgery, University of Minnesota, Minneapolis.

At the present time the interaction between the immune response of the tumor-bearing individual and his cancer is undergoing intense investigation. This has already provided a great deal of information about the etiology and biology of many tumors. The major goals, however, are earlier diagnosis and effective immunization as a new mode of therapy. The current dramatic expansion in our understanding of the immune system offers every hope that these goals will eventually be achieved with many tumors.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVECOVER ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by American Cancer Society.